Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines

References

• Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara K, Kadoya R. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 1995; 346:701 - 2; http://dx.doi.org/10.1016/S0140-6736(95)92311-X; PMID: 7658837
   PubMed Web of Science ®Google Scholar
• Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 1991; 10:209 - 13; http://dx.doi.org/10.1097/00006454-199103000-00008; PMID: 2041668
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Global routine vaccination coverage, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:1520 - 2; PMID: 22071590
   PubMedGoogle Scholar
• Duclos P, Okwo-Bele JM, Gacic-Dobo M, Cherian T. Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights 2009; 9:Suppl 1 S2; http://dx.doi.org/10.1186/1472-698X-9-S1-S2; PMID: 19828060
   PubMed Web of Science ®Google Scholar
• Dennehy PH. Active immunization in the United States: developments over the past decade. Clin Microbiol Rev 2001; 14:872 - 908; http://dx.doi.org/10.1128/CMR.14.4.872-908.2001; PMID: 11585789
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Vaccines: the fourth century. Clin Vaccine Immunol 2009; 16:1709 - 19; http://dx.doi.org/10.1128/CVI.00290-09; PMID: 19793898
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H. Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California. Eur J Pediatr 2002; 161:Suppl 2 S127 - 31; http://dx.doi.org/10.1007/s00431-002-1064-z; PMID: 12494258
   PubMedGoogle Scholar
• Olivier C, Belohradsky BH, Stojanov S, Bonnet E, Petersen G, Liese JG. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants. Vaccine 2008; 26:3142 - 52; http://dx.doi.org/10.1016/j.vaccine.2007.11.096; PMID: 18502545
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ, 085 Study Investigators. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. J Pediatr 2007; 151:43 - 9, e1-2; http://dx.doi.org/10.1016/j.jpeds.2007.02.013; PMID: 17586189
   PubMed Web of Science ®Google Scholar
• Siegrist CA. Vaccine immunology. Vaccines 6th edition, edited by Plotkin SA, Orenstein WA, Offit PA, Philadelphia, Elsevier Saunders, 2013, pp14-32.
   Google Scholar
• Philbin VJ, Levy O. Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res 2009; 65:98R - 105R; http://dx.doi.org/10.1203/PDR.0b013e31819f195d; PMID: 19918215
   PubMed Web of Science ®Google Scholar
• Palucka K, Banchereau J, Mellman I. Designing vaccines based on biology of human dendritic cell subsets. Immunity 2010; 33:464 - 78; http://dx.doi.org/10.1016/j.immuni.2010.10.007; PMID: 21029958
   PubMed Web of Science ®Google Scholar
• Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, Nakaya HI, Ravindran R, Stewart S, Alam M, Kwissa M, et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 2011; 470:543 - 7; http://dx.doi.org/10.1038/nature09737; PMID: 21350488
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783 - 801; http://dx.doi.org/10.1016/j.cell.2006.02.015; PMID: 16497588
   PubMed Web of Science ®Google Scholar
• Ichinohe T. Respective roles of TLR, RIG-I and NLRP3 in influenza virus infection and immunity: impact on vaccine design. Expert Rev Vaccines 2010; 9:1315 - 24; http://dx.doi.org/10.1586/erv.10.118; PMID: 21087109
   PubMed Web of Science ®Google Scholar
• Ichinohe T, Iwasaki A, Hasegawa H. Innate sensors of influenza virus: clues to developing better intranasal vaccines. Expert Rev Vaccines 2008; 7:1435 - 45; http://dx.doi.org/10.1586/14760584.7.9.1435; PMID: 18980544
   PubMed Web of Science ®Google Scholar
• Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140:821 - 32; http://dx.doi.org/10.1016/j.cell.2010.01.040; PMID: 20303873
   PubMed Web of Science ®Google Scholar
• Saïd-Sadier N, Ojcius DM. Alarmins, inflammasomes and immunity. Biomed J 2012; 35:437 - 49; http://dx.doi.org/10.4103/2319-4170.104408; PMID: 23442356
   PubMedGoogle Scholar
• Kool M, Soullié T, van Nimwegen M, Willart MA, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008; 205:869 - 82; http://dx.doi.org/10.1084/jem.20071087; PMID: 18362170
   PubMed Web of Science ®Google Scholar
• Spreafico R, Ricciardi-Castagnoli P, Mortellaro A. The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants. Eur J Immunol 2010; 40:638 - 42; http://dx.doi.org/10.1002/eji.200940039; PMID: 20201020
   PubMed Web of Science ®Google Scholar
• Batista-Duharte A, Lindblad EB, Oviedo-Orta E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett 2011; 203:97 - 105; http://dx.doi.org/10.1016/j.toxlet.2011.03.001; PMID: 21392560
   PubMed Web of Science ®Google Scholar
• Nakayama T, Kashiwagi Y, Kawashima H, Kumagai T, Ishii KJ, Ihara T. Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions. Vaccine 2012; 30:3885 - 90; http://dx.doi.org/10.1016/j.vaccine.2012.04.004; PMID: 22507655
   PubMed Web of Science ®Google Scholar
• Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009; 227:221 - 33; http://dx.doi.org/10.1111/j.1600-065X.2008.00731.x; PMID: 19120487
   PubMed Web of Science ®Google Scholar
• Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol 2011; 1:226 - 32; http://dx.doi.org/10.1016/j.coviro.2011.07.002; PMID: 22440781
   PubMed Web of Science ®Google Scholar
• Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47:87 - 103; http://dx.doi.org/10.1016/S0165-0378(00)00060-7; PMID: 10924744
   PubMed Web of Science ®Google Scholar
• Caron JE, La Pine TR, Augustine NH, Martins TB, Hill HR. Multiplex analysis of toll-like receptor-stimulated neonatal cytokine response. Neonatology 2010; 97:266 - 73; http://dx.doi.org/10.1159/000255165; PMID: 19955831
   PubMed Web of Science ®Google Scholar
• Burl S, Townend J, Njie-Jobe J, Cox M, Adetifa UJ, Touray E, Philbin VJ, Mancuso C, Kampmann B, Whittle H, et al. Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One 2011; 6:e18185; http://dx.doi.org/10.1371/journal.pone.0018185; PMID: 21533209
   PubMedGoogle Scholar
• Mogensen TH, Paludan SR, Kilian M, Østergaard L. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukoc Biol 2006; 80:267 - 77; http://dx.doi.org/10.1189/jlb.1105626; PMID: 16731773
   PubMed Web of Science ®Google Scholar
• Latz E, Franko J, Golenbock DT, Schreiber JR. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. J Immunol 2004; 172:2431 - 8; PMID: 14764714
   PubMed Web of Science ®Google Scholar
• Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010; 33:492 - 503; http://dx.doi.org/10.1016/j.immuni.2010.10.002; PMID: 21029960
   PubMed Web of Science ®Google Scholar
• Song BM, Kang YM, Kim HS, Seo SH. Induction of inflammatory cytokines and toll-like receptors in human normal respiratory epithelial cells infected with seasonal H1N1, 2009 pandemic H1N1, seasonal H3N2, and highly pathogenic H5N1 influenza virus. Viral Immunol 2011; 24:179 - 87; http://dx.doi.org/10.1089/vim.2010.0125; PMID: 21668359
   PubMed Web of Science ®Google Scholar
• Gupta RK, Relyveld EH, Lindblad EB, Bizzini B, Ben-Efraim S, Gupta CK. Adjuvants--a balance between toxicity and adjuvanticity. Vaccine 1993; 11:293 - 306; http://dx.doi.org/10.1016/0264-410X(93)90190-9; PMID: 8447157
   PubMed Web of Science ®Google Scholar
• Gribble EJ, Sivakumar PV, Ponce RA, Hughes SD. Toxicity as a result of immunostimulation by biologics. Expert Opin Drug Metab Toxicol 2007; 3:209 - 34; http://dx.doi.org/10.1517/17425255.3.2.209; PMID: 17428152
   PubMed Web of Science ®Google Scholar
• Kamgang RK, Ramos I, Rodrigues Duarte L, Ghielmetti M, Freudenberg M, Dahinden C, Padovan E. Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists. Med Microbiol Immunol 2008; 197:369 - 79; http://dx.doi.org/10.1007/s00430-008-0081-6; PMID: 18283493
   PubMed Web of Science ®Google Scholar
• Bartfai T, Conti B. Fever. ScientificWorldJournal 2010; 10:490 - 503; http://dx.doi.org/10.1100/tsw.2010.50; PMID: 20305990
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 2004; 10:201 - 22; PMID: 15373964
   PubMedGoogle Scholar
• Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone marrow. Immunology 2008; 125:281 - 8; http://dx.doi.org/10.1111/j.1365-2567.2008.02950.x; PMID: 19128361
   PubMed Web of Science ®Google Scholar
• Calabro S, Tortoli M, Baudner BC, Pacitto A, Cortese M, O’Hagan DT, De Gregorio E, Seubert A, Wack A. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 2011; 29:1812 - 23; http://dx.doi.org/10.1016/j.vaccine.2010.12.090; PMID: 21215831
   PubMed Web of Science ®Google Scholar
• Munks MW, McKee AS, Macleod MK, Powell RL, Degen JL, Reisdorph NA, Kappler JW, Marrack P. Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo. Blood 2010; 116:5191 - 9; http://dx.doi.org/10.1182/blood-2010-03-275529; PMID: 20876456
   PubMed Web of Science ®Google Scholar
• Pang T, Wang J, Benicky J, Sánchez-Lemus E, Saavedra JM. Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways. J Neuroinflammation 2012; 9:102; http://dx.doi.org/10.1186/1742-2094-9-102; PMID: 22642771
   PubMed Web of Science ®Google Scholar
• Kuroda E, Ishii KJ, Uematsu S, Ohata K, Coban C, Akira S, Aritake K, Urade Y, Morimoto Y. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 2011; 34:514 - 26; http://dx.doi.org/10.1016/j.immuni.2011.03.019; PMID: 21497116
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine immunogenetics: bedside to bench to population. Vaccine 2008; 26:6183 - 8; http://dx.doi.org/10.1016/j.vaccine.2008.06.057; PMID: 18598732
   PubMed Web of Science ®Google Scholar
• Poland GA, Kennedy RB, Ovsyannikova IG. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?. PLoS Pathog 2011; 7:e1002344; http://dx.doi.org/10.1371/journal.ppat.1002344; PMID: 22241978
   PubMed Web of Science ®Google Scholar
• Buonaguro L, Pulendran B. Immunogenomics and systems biology of vaccines. Immunol Rev 2011; 239:197 - 208; http://dx.doi.org/10.1111/j.1600-065X.2010.00971.x; PMID: 21198673
   PubMed Web of Science ®Google Scholar